Skip to content
OpenCapital
Get started

Ginkgo Bioworks DNA Market capitalization

Market capitalization at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$182.6B-2.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$8.49B+10.3%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.06B+59.2%
TEC
Bio-TechneTECH
$8.18B-11.8%
Azenta logo
AzentaAZTA
$973.28M-38.5%
Regenxbio logo
RegenxbioRGNX
$432.52M+20.8%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Computed from the period-end share price: $379.6M.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's market capitalization?
Ginkgo Bioworks (DNA) reported market capitalization of $379.6M in Q1 2026.
How has Ginkgo Bioworks's market capitalization changed year-over-year?
Ginkgo Bioworks's market capitalization increased by 14.8% year-over-year, from $330.79M to $379.6M.
What is the long-term trend for Ginkgo Bioworks's market capitalization?
Over 4 years (2021 to 2025), Ginkgo Bioworks's market capitalization has grown at a -56.4% compound annual growth rate (CAGR), from $13.9B to $503.5M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.